{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:23:24Z","timestamp":1784085804038,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This research was supported by the Bio &amp; Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science and ICT of Korea"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Preeclampsia is one of the most serious complications during pregnancy, defined as development of hypertension during late pregnancy affecting other organ systems (proteinuria, thrombocytopenia, renal insufficiency, liver involvement, cerebral symptoms or pulmonary edema). Preeclampsia is known to be associated with significant dyslipidemia, but the cause or mechanism of this metabolic aberration is not clear. Quantitative analysis of cholesterol precursors and metabolites can reveal metabolic signatures of cholesterol, and provide insight into cholesterol biosynthetic and degradation pathways. We undertook this study to compare the metabolic signatures of cholesterol in serum and amniotic fluid collected from women who delivered in the late preterm period. Matching serum and amniotic fluid samples were collected from women who delivered in the late preterm period (34-0\/7\u201336-6\/7 weeks), had undergone amniocentesis within 3 days of delivery, had no evidence of rupture of membranes or intra-amniotic infection\/inflammation, and who had not received antenatal corticosteroid prior to amniocentesis. Patients were classified into 3 groups according to the etiology of their preterm birth: Group 1, preeclampsia; Group 2, spontaneous preterm labor; Group 3, other maternal medical indications for iatrogenic preterm birth. Quantitative metabolite profiling of cholesterols was performed using gas chromatography-mass spectrometry. A total of 39 women were included in the analysis (n\u2009=\u200914 in Group 1, n\u2009=\u200916 in Group 2, n\u2009=\u20099 in Group 3). In maternal blood, patients in Group 1 had significantly higher ratios of cholesterol\/desmosterol and cholesterol\/7-dehydrocholesterol (which represent 24- and 7-reductase enzyme activity, respectively) than those in Group 3 (p\u2009&lt;\u20090.05 for each), which suggests increased cholesterol biosynthesis. In contrast, patients in Group 1 had significantly decreased ratios of individual cholesterol esters\/cholesterol and total cholesterol esters\/cholesterol than those in Groups 3 (p\u2009&lt;\u20090.01 for each), suggesting increased reverse cholesterol transport. No differences in cholesterol ratios were found in amniotic fluid among the 3 groups. In conclusion, the metabolic signatures of cholesterol suggest increased cholesterol biosynthesis and accumulation in the maternal blood (but not amniotic fluid) of women with preeclampsia.<\/jats:p>","DOI":"10.1038\/s41598-018-37757-3","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T11:05:41Z","timestamp":1549537541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Increased biosynthesis and accumulation of cholesterol in maternal plasma, but not amniotic fluid in pre-eclampsia"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2543-0408","authenticated-orcid":false,"given":"Seung Mi","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Yeon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Yun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Kwan","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol R.","family":"Norwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong Shin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"37757_CR1","unstructured":"American College of, O., Gynecologists & Task Force on Hypertension in, P. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol 122, 1122\u201331 (2013)."},{"key":"37757_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/10641955.2010.525277","volume":"31","author":"JN Martin Jr.","year":"2012","unstructured":"Martin, J. N. Jr. et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy 31, 79\u201390 (2012).","journal-title":"Hypertens Pregnancy"},{"key":"37757_CR3","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan, K. S., Wojdyla, D., Say, L., Gulmezoglu, A. M. & Van Look, P. F. WHO analysis of causes of maternal death: a systematic review. Lancet 367, 1066\u201374 (2006).","journal-title":"Lancet"},{"key":"37757_CR4","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/AOG.0b013e3181fdfb11","volume":"116","author":"CJ Berg","year":"2010","unstructured":"Berg, C. J., Callaghan, W. M., Syverson, C. & Henderson, Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 116, 1302\u20139 (2010).","journal-title":"Obstet Gynecol"},{"key":"37757_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/AOG.0b013e31829fc38c","volume":"122","author":"M Saucedo","year":"2013","unstructured":"Saucedo, M., Deneux-Tharaux, C. & Bouvier-Colle, M. H. & French National Experts Committee on Maternal, M. Ten years of confidential inquiries into maternal deaths in France, 1998\u20132007. Obstet Gynecol 122, 752\u201360 (2013).","journal-title":"Obstet Gynecol"},{"key":"37757_CR6","doi-asserted-by":"publisher","first-page":"66 e1","DOI":"10.1016\/j.ajog.2013.09.010","volume":"210","author":"DB Nelson","year":"2014","unstructured":"Nelson, D. B., Ziadie, M. S., McIntire, D. D., Rogers, B. B. & Leveno, K. J. Placental pathology suggesting that preeclampsia is more than one disease. Am J Obstet Gynecol 210, 66 e1\u20137 (2014).","journal-title":"Am J Obstet Gynecol"},{"key":"37757_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09513590500097382","volume":"21","author":"G Bayhan","year":"2005","unstructured":"Bayhan, G., Kocyigit, Y., Atamer, A., Atamer, Y. & Akkus, Z. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol Endocrinol 21, 1\u20136 (2005).","journal-title":"Gynecol Endocrinol"},{"key":"37757_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/09513590400018108","volume":"19","author":"Y Kocyigit","year":"2004","unstructured":"Kocyigit, Y., Atamer, Y., Atamer, A., Tuzcu, A. & Akkus, Z. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol Endocrinol 19, 267\u201373 (2004).","journal-title":"Gynecol Endocrinol"},{"key":"37757_CR9","first-page":"432","volume":"60","author":"U Iftikhar","year":"2010","unstructured":"Iftikhar, U., Iqbal, A. & Shakoor, S. Relationship between leptin and lipids during pre-eclampsia. J Pak Med Assoc 60, 432\u20135 (2010).","journal-title":"J Pak Med Assoc"},{"key":"37757_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/aje\/kwu145","volume":"180","author":"CN Spracklen","year":"2014","unstructured":"Spracklen, C. N., Smith, C. J., Saftlas, A. F., Robinson, J. G. & Ryckman, K. K. Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am J Epidemiol 180, 346\u201358 (2014).","journal-title":"Am J Epidemiol"},{"key":"37757_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jsbmb.2015.04.014","volume":"153","author":"HS Seo","year":"2015","unstructured":"Seo, H. S. & Choi, M. H. Cholesterol homeostasis in cardiovascular disease and recent advances in measuring cholesterol signatures. J Steroid Biochem Mol Biol 153, 72\u20139 (2015).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"37757_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jsbmb.2015.02.012","volume":"149","author":"HH Son","year":"2015","unstructured":"Son, H. H. et al. Serum sterol profiling reveals increased cholesterol biosynthesis in childhood obesity. J Steroid Biochem Mol Biol 149, 138\u201345 (2015).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"37757_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0735-1097(00)00527-1","volume":"35","author":"RA Rajaratnam","year":"2000","unstructured":"Rajaratnam, R. A., Gylling, H. & Miettinen, T. A. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 35, 1185\u201391 (2000).","journal-title":"J Am Coll Cardiol"},{"key":"37757_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.numecd.2011.04.010","volume":"21","author":"G Lupattelli","year":"2011","unstructured":"Lupattelli, G., De Vuono, S. & Mannarino, E. Patterns of cholesterol metabolism: pathophysiological and therapeutic implications for dyslipidemias and the metabolic syndrome. Nutr Metab Cardiovasc Dis 21, 620\u20137 (2011).","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"37757_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.placenta.2011.03.012","volume":"32","author":"SM Lee","year":"2011","unstructured":"Lee, S. M., Lee, K. A., Kim, S. M., Park, C. W. & Yoon, B. H. The risk of intra-amniotic infection, inflammation and histologic chorioamnionitis in term pregnant women with intact membranes and labor. Placenta 32, 516\u201321 (2011).","journal-title":"Placenta"},{"key":"37757_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1067\/mob.2000.104207","volume":"182","author":"BH Yoon","year":"2000","unstructured":"Yoon, B. H. et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 182, 675\u201381 (2000).","journal-title":"Am J Obstet Gynecol"},{"key":"37757_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1067\/mob.2001.117679","volume":"185","author":"JS Park","year":"2001","unstructured":"Park, J. S. et al. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol 185, 1156\u201361 (2001).","journal-title":"Am J Obstet Gynecol"},{"key":"37757_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jsbmb.2015.09.024","volume":"155","author":"HH Son","year":"2016","unstructured":"Son, H. H. et al. Hair sterol signatures coupled to multivariate data analysis reveal an increased 7beta-hydroxycholesterol production in cognitive impairment. J Steroid Biochem Mol Biol 155, 9\u201317 (2016).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"37757_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1194\/jlr.D040790","volume":"55","author":"HH Son","year":"2014","unstructured":"Son, H. H. et al. High-temperature GC-MS-based serum cholesterol signatures may reveal sex differences in vasospastic angina. J Lipid Res 55, 155\u201362 (2014).","journal-title":"J Lipid Res"},{"key":"37757_CR20","first-page":"365","volume":"53","author":"S Sahu","year":"2009","unstructured":"Sahu, S., Abraham, R., Vedavalli, R. & Daniel, M. Study of lipid profile, lipid peroxidation and vitamin E in pregnancy induced hypertension. Indian J Physiol Pharmacol 53, 365\u20139 (2009).","journal-title":"Indian J Physiol Pharmacol"},{"key":"37757_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000087205","volume":"60","author":"H Uzun","year":"2005","unstructured":"Uzun, H. et al. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obstet Invest 60, 195\u2013200 (2005).","journal-title":"Gynecol Obstet Invest"},{"key":"37757_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00404-013-2750-y","volume":"288","author":"T Emet","year":"2013","unstructured":"Emet, T. et al. Plasma lipids and lipoproteins during pregnancy and related pregnancy outcomes. Arch Gynecol Obstet 288, 49\u201355 (2013).","journal-title":"Arch Gynecol Obstet"},{"key":"37757_CR23","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1194\/jlr.M036699","volume":"54","author":"MR Hentschke","year":"2013","unstructured":"Hentschke, M. R. et al. Is the atherosclerotic phenotype of preeclamptic placentas due to altered lipoprotein concentrations and placental lipoprotein receptors? Role of a small-for-gestational-age phenotype. J Lipid Res 54, 2658\u201364 (2013).","journal-title":"J Lipid Res"},{"key":"37757_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1055\/s-2007-1016250","volume":"16","author":"B Lorentzen","year":"1998","unstructured":"Lorentzen, B. & Henriksen, T. Plasma lipids and vascular dysfunction in preeclampsia. Semin Reprod Endocrinol 16, 33\u20139 (1998).","journal-title":"Semin Reprod Endocrinol"},{"key":"37757_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00001648-199605000-00016","volume":"7","author":"F Parazzini","year":"1996","unstructured":"Parazzini, F. et al. Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group. Epidemiology 7, 306\u20138 (1996).","journal-title":"Epidemiology"},{"key":"37757_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-12-387042-1.00007-1","volume":"55","author":"A Ghio","year":"2011","unstructured":"Ghio, A., Bertolotto, A., Resi, V., Volpe, L. & Di Cianni, G. Triglyceride metabolism in pregnancy. Adv Clin Chem 55, 133\u201353 (2011).","journal-title":"Adv Clin Chem"},{"key":"37757_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bmj.325.7356.157","volume":"325","author":"N Sattar","year":"2002","unstructured":"Sattar, N. & Greer, I. A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 325, 157\u201360 (2002).","journal-title":"BMJ"},{"key":"37757_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/01443615.2017.1286463","volume":"37","author":"S Kharb","year":"2017","unstructured":"Kharb, S., Bala, J. & Nanda, S. Markers of obesity and growth in preeclamptic and normotensive pregnant women. J Obstet Gynaecol 37, 610\u2013615 (2017).","journal-title":"J Obstet Gynaecol"},{"key":"37757_CR29","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","volume":"371","author":"A Rohatgi","year":"2014","unstructured":"Rohatgi, A. et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med 371, 2383\u201393 (2014).","journal-title":"N Engl J Med"},{"key":"37757_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1194\/jlr.M071985","volume":"58","author":"HD Mistry","year":"2017","unstructured":"Mistry, H. D. et al. Increased maternal and fetal cholesterol efflux capacity and placental CYP27A1 expression in preeclampsia. J Lipid Res 58, 1186\u20131195 (2017).","journal-title":"J Lipid Res"},{"key":"37757_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12944-018-0698-4","volume":"17","author":"C Contini","year":"2018","unstructured":"Contini, C. et al. Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study. Lipids Health Dis 17, 49 (2018).","journal-title":"Lipids Health Dis"},{"key":"37757_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajog.2011.07.017","volume":"205","author":"Publications Committee, S.f.M.-F.M. & Sibai, B.M","year":"2011","unstructured":"Publications Committee, S. f. M.-F. M. & Sibai, B. M. Evaluation and management of severe preeclampsia before 34 weeks\u2019 gestation. Am J Obstet Gynecol 205, 191\u20138 (2011).","journal-title":"Am J Obstet Gynecol"},{"key":"37757_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1515\/jpm.2011.135","volume":"40","author":"U Pecks","year":"2012","unstructured":"Pecks, U. et al. Maternal and fetal cord blood lipids in intrauterine growth restriction. J Perinat Med 40, 287\u201396 (2012).","journal-title":"J Perinat Med"},{"key":"37757_CR34","doi-asserted-by":"crossref","unstructured":"Brownfoot, F. C. et al. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia. Hypertension 66, 687\u201397; discussion 445 (2015).","DOI":"10.1161\/HYPERTENSIONAHA.115.05445"},{"key":"37757_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-016-0902-3","volume":"16","author":"FC Brownfoot","year":"2016","unstructured":"Brownfoot, F. C. et al. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta. BMC Pregnancy Childbirth 16, 117 (2016).","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37757-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:40:41Z","timestamp":1671255641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37757-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37757"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37757-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"4 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1550"}}